Rxsight Inc reports results for the quarter - Earnings Summary

• Rxsight Inc RXST.OQ reported a quarterly adjusted loss of 16 cents​​ per share for the quarter , higher than the same quarter last year, when the company reported EPS of -31 cents. The mean expectation of nine analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -34 cents to -18 cents per share.

• Revenue rose 59.1% to $35.31 million from a year ago; analysts expected $35.06 million.

• Rxsight Inc's reported EPS for the quarter was a loss of 16 cents​.

• The company reported a quarterly loss of $6.34 million.

• Rxsight Inc shares had risen by 2.9% this quarter and gained 26.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 7.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Rxsight Inc is 65.00

This summary was machine generated from LSEG data November 9 at 12:28 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)